Focus of the Conference: Progress in ADC Treatment for Breast Cancer at ESMO 2025

[Image]The 2025 European Society for Medical Oncology (ESMO 2025) Annual Meeting will be held from October 17 to 21 in Berlin, Germany. With the continuous development of precision medicine and personalized treatment, Antibody-Drug Conjugates (ADC) continue to be a significant focus of this conference. Currently, the ESMO official website has announced some oral presentation and poster titles, and BEST ONCO will specifically highlight ADC in the field of breast cancer…

Related posts

  1. Unable to Connect to the Internet After Flashing LineageOS? A Comprehensive Guide to Resolving IP Configuration Failures and Network Restrictions
  2. AI Chatbots: Your Intelligent Companion or a Cognitive Trap?
  3. Media Focus | AI and Robotics College’s ‘Dream Building’ Practice Team Conducts Technology Enlightenment and Livelihood Research in Mu Jiao Village
  4. Precise Coupling Mechanism of ADC Linkers and Crosslinkers: Targeted Release and Structural Regulation
  5. The Era of ADC: From Imitation to Leadership, Reshaping the Global Innovative Drug Landscape
  6. ERICA Study: Preventing Nausea and Vomiting Associated with Novel HER2 ADC Treatment
  7. Common Faults of CAN Bus and Multimeter Troubleshooting Methods
  8. The Rise of Chip Stocks Reflects National Fortune, While the Fall Tests Retail Investors’ Patience
  9. Robot Path Planning Simulation with MATLAB Code

Leave a Comment